Type I Interferonopathies: Fifteen Years On, From Concept to Therapeutic Perspectives.

Saved in:
Bibliographic Details
Title: Type I Interferonopathies: Fifteen Years On, From Concept to Therapeutic Perspectives.
Authors: Ünal D; Université Paris Cité, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, INSERM UMR 1163, Paris, 75015, France.; Department of Pediatrics, Division of Pediatric Rheumatology, Hacettepe University, Ankara, Türkiye., Melki I; Université Paris Cité, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, INSERM UMR 1163, Paris, 75015, France. isabelle.melki@aphp.fr.; Department of General Pediatrics, Paediatric Rheumatology Unit, Armand-Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, FHU INFLAMME, Paris, 75012, France. isabelle.melki@aphp.fr., Frémond ML; Université Paris Cité, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, INSERM UMR 1163, Paris, 75015, France. marie-louise.fremond@aphp.fr.; Paediatric Immuno-Hematology and Rheumatology Department,Hôpital Necker-Enfants Malades, AP-HP. Centre Université Paris Cité, Reference Centre for Inflammatory Rheumatism, Autoimmune Diseases and Systemic Interferonopathies in Children (RAISE), FHU INFLAMME, F-CRIN CRI-IMIDIATE network, Paris, 75015, France. marie-louise.fremond@aphp.fr.
Source: Current rheumatology reports [Curr Rheumatol Rep] 2026 Jul 04; Vol. 28 (1). Date of Electronic Publication: 2026 Jul 04.
Publication Type: Journal Article; Review
Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 100888970 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6307 (Electronic) Linking ISSN: 15233774 NLM ISO Abbreviation: Curr Rheumatol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1534-6307
DOI:10.1007/s11926-026-01228-w